Navigation Links
HeartWare International Reports Fourth Quarter 2012 Revenue Of $32.7 Million; Full Year 2012 Revenue Of $110.9 Million
Date:2/27/2013

e, in fiscal 2011.

At December 31, 2012, the Company had $102.8 million of cash, cash equivalents and investments.

HeartWare will host a conference call on Wednesday, February 27, 2013 at 8:30 a.m., U.S. Eastern Standard Time to discuss the Company's financial results, highlights from the fourth quarter and business outlook.  The call may be accessed by dialing 1-888-846-5003 five minutes prior to the scheduled start time and referencing "HeartWare."  For callers outside the U.S., please dial +1-480-629-9856.

A live webcast of the call will also be available at the Company's website (www.heartware.com) by selecting "HeartWare Fourth Quarter 2012 Conference Call" under the section titled "Corporate Presentations" on the Home Page.  A replay of the conference call will be available through the above weblink immediately following completion of the call.

About HeartWare InternationalHeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure. The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-support circulatory assist device designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices. The HeartWare System is approved in the United States for the intended use as a bridge to cardiac transplantation in patients who are at risk of death from refractory end-stage left ventricular heart failure, has received CE Marking in the European Union and has been used to treat patients in 28 international countries. The device is also currently the subject of a U.S. clinical trial for destination therapy. For additional information, please visit the Company's website at www.heartware.com.
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. HeartWare Schedules Fourth Quarter Conference Call and Webcast
2. HeartWare Presentation at Leerink Swann Global Healthcare Conference to be Webcast
3. HeartWare Presentation at the Oppenheimer 23rd Annual Healthcare Conference to be Webcast
4. HeartWare Presentation At The 24th Annual Piper Jaffray Healthcare Conference To Be Webcast
5. HeartWare Presentation At The Lazard Capital Markets 9th Annual Healthcare Conference To Be Webcast
6. HeartWare Reports Third Quarter 2012 Results
7. HeartWare Schedules Third Quarter Conference Call And Webcast
8. HeartWare Presentation at the UBS Global Life Sciences Conference to be Webcast
9. HeartWare Presentation At The Canaccord Genuity 32nd Annual Growth Conference To Be Webcast
10. HeartWare Presentation at the 2012 Wedbush PacGrow Lifesciences Management Access Conference to be Webcast
11. HeartWare Reports Second Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... and OR YEHUDA, Israel , Sept. ... HTWR ), a leading innovator of less invasive, ... of advanced heart failure, announced today that it has ... Cardio, Ltd . ("Valtech").  Valtech is a privately held ... and transcatheter valve repair and replacement devices for the ...
(Date:9/1/2015)... Ark. , Sept. 1, 2015 NOWDiagnostics Inc., based ... its acquisition of ZBx Corporation of Canada ... its vision of a world where people have greater ... manufactures and sells a line of unique blood-based rapid ... highly accurate tests for a variety of ailments and ...
(Date:9/1/2015)... Sept. 1, 2015 Emerus Holdings, a ... emergent, inpatient and diagnostic care in partnership with ... a definitive agreement to receive a strategic investment ... a leading health care investment firm. ... patient-centric acute episodic and ambulatory clinical services to ...
Breaking Medicine Technology:HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 2HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 3HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 4HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 5HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 6HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 7HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 8HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 9HeartWare International Enters Into Definitive Agreement To Acquire Valtech Cardio, Ltd. 10NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 2NOWDiagnostics Inc. Acquires Canada's ZBx Corporation 3Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 2Emerus Announces Significant Strategic Investment By Welsh, Carson, Anderson & Stowe 3
... , SAN CARLOS, Calif., ... today announced the promotion of Lorianne Masuoka, M.D. to ... Masuoka will report directly to Nektar,s President and Chief ... outstanding leadership and highly effective clinical development strategies have ...
... TORONTO, Nov. 30 The Special Committee of Independent Directors ... JLL Partners, Inc. and its affiliate, JLL Patheon Holdings, LLC ... entered into a settlement agreement in respect of the pending ... provides among other things that: , until March 2011, ...
Cached Medicine Technology:Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3Patheon and JLL Partners Announce Litigation Settlement 2Patheon and JLL Partners Announce Litigation Settlement 3
(Date:9/1/2015)... ... September 01, 2015 , ... Consumers overwhelmingly prefer to have ... Surgery, according to a new survey that also offers insight on why that ... – which reflects views on cosmetic medical treatments and ratings for 10 specific ...
(Date:9/1/2015)... ... September 01, 2015 , ... Negative pressure wound ... a wound to remove exudates, fluid, and infectious materials to prepare the wound ... devices, disposable devices, and canisters, etc.) is projected to expand continuously through 2021. ...
(Date:9/1/2015)... ... September 01, 2015 , ... OncLive® today announced ... News & World Report, to provide breaking news and information about the hospital’s ... within OncLive, which provides oncologists resources and information?they need to deliver the best ...
(Date:9/1/2015)... ... 2015 , ... PetPace, the provider of an innovative IoT ... today announced its integration with leading veterinary Practice Management Software vendor Cornerstone. ... Management Software packages in the US. Practice Management Software helps veterinarians manage every ...
(Date:9/1/2015)... ... September 01, 2015 , ... e-Spirit Inc., a leading ... the FirstSpirit Content Management System with new capabilities and enhancements designed to support ... companies will be well on their way to achieving digital transformation with less ...
Breaking Medicine News(10 mins):Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 3Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 2Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 3Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 2Health News:e-Spirit boosts Corporate Content Cloud initiative with release of FirstSpirit 5.2 3
... Patients on immunosuppressants should seek medical attention at ... 2008 A new Mayo,Clinic study finds that ... multiple,immunosuppressive medications for inflammatory bowel disease have a ... in this month,s,issue of Gastroenterology., More than ...
... DIEGO, April 2, 2008 Naviscan PET Systems, a,privately ... announced today that a contract has been signed to ... D. Anderson Cancer Center in,Houston. Naviscan,s PEM Flex(TM) Solo ... since the second quarter of 2007., M. D. ...
... Honored by National Science Board and,Council on Foundations ... Bayer Corporation,the health care, nutrition and innovative materials ... will be honored, respectively,by the National Science Board ... of science education and science literacy at two,separate ...
... April 2, 2008 /PRNewswire/ - The latest health data ... lag the,nation and benchmark cities when it comes to ... indicators based on information,from a 2006 report from the ... http://www.pittsburghtoday.org, the Pittsburgh Regional Indicator,project web site., ...
... of Health, Take off Pounds to ... Gain Healthier Lives, NEW ... difference people can make when they join together to confront a,serious challenge. ... Ian Smith, Patti LaBelle, Yolanda Adams, Michael Strahan,Steve Harvey and other leaders ...
... PocketCPR(TM), an FDA-cleared, palm-sized device that assists a ... resuscitation (CPR) chest compressions will be ... or hands-only cardiopulmonary resuscitation (CPR), to ... Arizona. (Photo: http://www.newscom.com/cgi-bin/prnh/20080402/NEW076 ), ...
Cached Medicine News:Health News:Mayo Clinic Identifies Infection Risks for Patients with Inflammatory Bowel Disease 2Health News:Bayer to Receive Two Top National Awards for Its Science Education, Science Literacy Work 2Health News:Bayer to Receive Two Top National Awards for Its Science Education, Science Literacy Work 3Health News:Bayer to Receive Two Top National Awards for Its Science Education, Science Literacy Work 4Health News:Bayer to Receive Two Top National Awards for Its Science Education, Science Literacy Work 5Health News:Bayer to Receive Two Top National Awards for Its Science Education, Science Literacy Work 6Health News:Pittsburghers Slow to Quit 2Health News:50 Million Pound Challenge Marks 1st Anniversary - What a Difference a Year Makes! 2Health News:50 Million Pound Challenge Marks 1st Anniversary - What a Difference a Year Makes! 3Health News:50 Million Pound Challenge Marks 1st Anniversary - What a Difference a Year Makes! 4Health News:State of Arizona to Use PocketCPR for Training Initiative on Hands-Only CPR 2
... a whole blood hematology control manufactured specifically ... 120, and the Coulter AcT5diff instruments. The ... white cell differential, positioning the populations within ... systems. The product offers 105-day closed-vial stability ...
... assayed hematology control, offers complete assay values ... with the Coulter GENS, STKS, MAXM and ... stability, 105-day closed-vial stability and is available ... 4.0ml pierceable cap vial is compatible with ...
Abiomed introduces its new intra-aortic balloon (IAB); an easy-to-insert, minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart...
Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface....
Medicine Products: